Early amniocentesis for prenatal cytogenetic evaluation.

Area of Science:

• Maternal-Fetal Medicine
• Prenatal Diagnosis
• Genetics

Background:

• Traditional amniocentesis is typically performed later in pregnancy.
• Chorionic villus sampling (CVS) is an alternative but has its own set of disadvantages.
• Evaluating early amniocentesis offers potential benefits for earlier genetic screening.

Purpose of the Study:

• To assess the safety and efficacy of early amniocentesis (11-14 weeks gestation).
• To compare early amniocentesis with later amniocentesis procedures.
• To determine the feasibility of obtaining adequate fetal cells for karyotyping at an earlier gestational age.

Main Methods:

• Prospective evaluation of 100 consecutive patients undergoing early amniocentesis.
• Standard cytogenetic analysis for fetal karyotyping.
• Follow-up assessment of pregnancy outcomes and procedural complications.

Main Results:

• No procedure-related complications or pregnancy losses were observed.
• Adequate cell growth for karyotyping was achieved in 97% of cases; repeat procedures were successful.
• Five abnormal karyotypes were identified, with one confirmed as a culture artifact.
• 94 out of 95 pregnancies with normal karyotypes progressed normally.

Conclusions:

• Early amniocentesis at 11-14 weeks gestation is a safe and viable option for prenatal diagnosis.
• This technique provides results earlier in gestation compared to traditional amniocentesis.
• Early amniocentesis may offer advantages over chorionic villus sampling, potentially reducing procedural risks and providing earlier genetic information.